Macula Plus is an exceptional supplement containing lutein, zeaxanthin and astaxanthin in ideal amounts. It is developed from Tagetes erecta, a plant that supports eye health.
What is in Macula Plus?
The formulation Macula Plus contains four different antioxidants:
-
Lutein is a carotenoid pigment not produced by the body, but provided solely by the diet. It’s found in eggs, but primarily in dark green vegetables - kale (24 mg par portion), spinach (20 mg), marrow (3 à 4 mg), broccoli (2 mg), peas (2 mg) – as well as in corn (2 mg)…
By way of comparison, the supplement Macula Plus contains 10 mg per daily dose (1 softgel).
Research shows that Western populations consume just 1g-2g a day on average (1). Smokers and regular drinkers are likely to have increased requirements for lutein.
-
Astaxanthin is a pink-to-red coloured molecule with strong antioxidant potency, also from the carotenoid family. It is mainly found in seafood : red algae, salmon (2mg-3mg per portion of Atlantic salmon), trout, crab, shrimps, lobster, crayfish … Wild species are thought to have a higher astaxanthin content than their farmed equivalents.
Astaxanthin’s fragility and sensitivity to light and heat, coupled with its low solubility, make it a particularly precious compound. Even more so as astaxanthin-containing foods are eaten less and less by Western populations, and are increasingly contaminated by heavy metals.
The formulation Macula Plus contains 2mg per daily dose .
- Zeaxanthin, again not produced by the body, is the pigment responsible for the colour of paprika, corn and saffron. It’s primarily found in plant leaves, so in cabbages, Swiss chard, mustard greens, spinach, Romaine lettuce, dandelion leaves, watercress, and also spirulina.
Macula Plus contains 5mg per daily dose (2.5 mg of zeaxanthin + 2.5 mg of meso-zeaxanthin, its stereoisomer).
- Cyanidine-3-glucoside is a relatively unstable pigment found mainly in red fruits and the petals of brightly-coloured flowers. Raspberries (0.5mg per 100g), blackcurrants (25mg), cherries (18mg), cranberries (8mg) and pomegranate juice (3mg) are the main dietary sources but they’re unfortunately very seasonal …
Macula Plus provides around 4mg per softgel.
How does Macula Plus differ from other supplements of this kind?
- Many supplements contain pathetically-low levels of lutein (0.25mg-2mg), which are much too low to have a significant effect.
- Taking several carotenoids at the same time is thought to boost their action (synergistic effect). There are very few formulations offering lutein, astaxanthin and zeaxanthin in a single softgel.
- Macula plus contains healthy fatty acids which promote the absorption of the liposoluble carotenoids.
Daily dose : 1 softgel
Number of doses per pack : 60 |
Amount per dose |
Nutri-Mz® (extract of Tagetes erecta)
- Lutein
- Zeaxanthin*
- Meso-zeaxanthin |
10 mg
1.5 mg
2.5 mg |
Zeaxanthin* |
1 mg |
Astaxanthin |
2 mg |
Cyanidin-3-glucoside |
4 mg |
Other ingredients : beeswax, sunflower oil, sunflower lecithin.
Nutri-Mz® - Howard Foundation, UK.
US Patents #6,218,436 & 6,329,432, European Patent # 0 831 797.
|
(*Making a total of 2.5 mg zeaxanthin)
Adults. Take one softgel a day, with food, or as advised by your therapist.
Note : the new version of the product does not contain soy but sunflower derivatives (if you receive a product with a label indicating it contains soybean oil and soy lecithin as an excipient in a batch of Macula Plus purchased on or after 23 August 2024, this is a labelling error: the product you have received does not contain soy and labels will be corrected for the next batch).
- Mares-Perlman JA, Millen AE, et al. The body of evidence to support a protective role for lutein and zeaxanthin in delaying chronic disease. Overview. J Nutr. 2002 Mar;132(3):518S-524S. Review.
- Rougier MB, Delyfer MN, Korobelnik JF. Le pigment maculaire et sa mesure in vivo. Journal Français d'Ophtalmologie, Vol 31, N° 4 - avril 2008 pp. 445-453, Doi : JFO-04-2008-31-4-0181-5512-101019-200802524
- Engles M, Wooten B, Hammond B. Macular Pigment: a test of the acuity hypothesis. Invest Ophthalmol Vis Sci, 2007;48:2922-31.